Fellow Scientist
Regeneron Pharmaceuticals Inc
Tarrytown, New York
Dr. Ching Ha (Vicky) Lai is a Fellow Scientist in Bioanalytical Sciences Department at Regeneron. In her current role, she is responsible for developing bioanalytical strategies, overseeing regulated bioanalysis and immunogenicity for various protein therapeutics and novel modalities. Dr. Lai has been involved in multiple global regulatory marketing submissions. Prior to Regeneron, she served as Research Investigator at Novartis and Principal Scientist at Valeant Pharmaceuticals International, where her group was responsible for anti-viral drug development from discovery to late-phase clinical development. She earned her doctoral degree from the Chinese University of Hong Kong and completed her postdoctoral training at Merck (formerly Schering Plough Research Institute).
Disclosure information not submitted.
Challenging Current Immunogenicity Assessment: Clinical Case Studies for 1-Tiered Approach
Wednesday, October 23, 2024
9:30 AM – 10:00 AM MT